本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

73.63
-0.7000-0.94%
成交量:80.18万
成交额:5,886.58万
市值:121.63亿
市盈率:-30.94
高:74.27
开:74.05
低:72.42
收:74.33
52周最高:86.74
52周最低:23.95
股本:1.65亿
流通股本:1.64亿
量比:0.48
换手率:0.49%
股息:- -
股息率:- -
每股收益(TTM):-2.3800
每股收益(LYR):-2.3812
净资产收益率:-70.80%
总资产收益率:-7.31%
市净率:24.87
市盈率(LYR):-30.92

数据加载中...

2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/08

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities